Therapeutics

#Biosecurity #Cell programming #Defense Advanced Research Projects Agency #Ginkgo Bioworks #Proteins #Therapeutic proteins #Therapeutics

Ginkgo Bioworks awarded DARPA contract for therapeutic proteins 

The Defense Advanced Research Projects Agency (DARPA) has announced that Ginkgo Bioworks, which is building a platform for cell programming and biosecurity, has been awarded a four-year contract worth up to $18 million to reimagine how to manufacture complex therapeutic proteins.   As a performer on DARPA's Reimagining Protein Manufacturing… Read More

#News #Regulatory

Genetic engineering concept with medication capsule with human brain diagram at programming language background
#Antibody #Drug discovery #Immuno-oncology #Therapeutic Antibodies #Therapeutics

DDW Summer 2023 issue out now

The Summer 2023 issue of Drug Discovery World Magazine is out now and includes an exclusive guide on Therapeutic Antibodies.  Featuring a Therapeutic Spotlight on Immuno-oncology, the magazine is available to download free here and read for free on the DDW App.  You can also… Read More

#News

#Alchemab Therapeutics #Alzheimer's #Antibodies #Therapeutics

Alchemab unveils newly discovered Alzheimer’s candidate 

Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, has unveiled data on ATLX-1088, its newly-discovered preclinical Alzheimer’s candidate.   The data was announced at the Antibody Industrial Symposium in Tours, France, June 22-23, 2023.  ATLX-1088 is a potential… Read More

#News

Double stranded DNA molecule with mutation in a gene
#Cystic fibrosis #Life sciences #Seed funding #Start-ups #Therapeutics

€2m raised in seed funding to develop novel therapies for Cystic Fibrosis  

Anoat Therapeutics, a preclinical stage biotechnology company specialised in Cystic Fibrosis (CF), has raised €2m ($2.17m) in seed funding from AdBio partners, a venture capital company specialised in seed investments in life sciences startups.   This investment from the AFB FII fund stems from the AdBio-Inserm Transfert partnership… Read More

#News #Start-up Zone

#Contract Research Organisations (CROs) #Digitalisation #Proscia #Research #Therapeutics

Key findings from life sciences digital pathology adoption survey 

Nearly three-fourths of life sciences organisations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia. Over half of these organisations (53%) still center their operations around legacy software systems primarily for basic image viewing despite growing adoption of… Read More

#Editor's Choice #News

Cancer cells
#AACR 2023 #Cancer research #DDW Events podcast #Kintara Therapeutics #Meet the Researcher #Therapeutics

DDW Events: AACR 2023 Episode 1 with Dennis Brown, Kintara Therapeutics

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW’s Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. In this latest episode, Thomas speaks with Dennis Brown, Chief Scientific Officer at Kintara Therapeutics. You… Read More

#Podcasts

#AACR 2023 #Cancer research #DDW Events podcast #Kintara Therapeutics #Meet the Researcher #Therapeutics

Meet the researcher: Dennis Brown, Kintara Therapeutics 

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW's Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. Thomas speaks with Dennis Brown, Chief Scientific Officer at Kintara Therapeutics. You can also listen to these… Read More

#Cancer Research #Exclusive Content #Opinion

#AACR 2023 #Cancer #Cancer immunotherapy #Cancer research #Oncology #Therapeutics

Eight announcements to expect at AACR 2023   

The American Association for Cancer Research (AACR) Annual Meeting is taking place at the Orange County Convention Center in Orlando, Florida from April 14-19, 2023. As the theme, Advancing the Frontiers of Cancer Science and Medicine, suggests, a number of announcements, results and presentations will take place… Read More

#News

#Biologics #Biology #Biotechnology #Drug development #Therapeutics

Next-generation pipeline for treating mast cell driven diseases 

Granular Therapeutics, a UK-based biotech company specialising in precision biologic therapies for treating mast cell driven disorders, announced clinical candidate selection for its lead programme which has demonstrated promising results in initial preclinical studies.  Granular Therapeutics has now commenced proof-of-concept (POC) and IND-enabling studies as it prepares… Read More

#News

#Biotechnology #Cancer #Fibrotic disease #Monotherapy #Small molecul #Therapeutics

Topline data from Phase II monotherapy module

Redx, a clinical-stage biotechnology company focused on discovering and developing novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic disease, has shared topline monotherapy data from the biliary tract cancer (BTC) module of the RXC004 PORCUPINE2 Phase II clinical trial programme. RXC004 is an… Read More

#News

#AI / data analytics / healthtech / informatics #Data science #Lab automation #Life science #Machine learning #Proteins #Proteomics #SLAS2023 #Therapeutics

Don’t miss the DDW Events podcast series for SLAS2023

Today marks the start of SLAS2023 in San Diego. Over the last week, DDW’s Megan Thomas has narrated five articles from the SLAS2023 supplement as part of the DDW Events podcast series. Episodes include: A Welcome to SLAS 2023 Acquiring deeper insights and acceleration with AI Connecting… Read More

#News

#Biomedicine #Cloud computing #High throughput screening #Lab automation #Life sciences #Machine learning #Proteins #Proteomics #SLAS2023 #Therapeutics

Podcast: ML and lab automation are changing protein therapeutics

Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW SLAS2023 supplement as part of the DDW Events podcast series. This is episode four, How machine learning and lab automation are changing the… Read More

#News

#AI / data analytics / healthtech / informatics #Biomarkers #Drug discovery #SLAS2023 #Therapeutics

Podcast: Acquiring deeper insights and acceleration with AI

Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW SLAS2023 supplement as part of the DDW Events podcast series. This is episode two, Acquiring deeper insights and acceleration with AI. At IBM… Read More

#News

Protein degradation
#Biology #CRO #Drug development #Drug discovery #Genomics #Protein chemistry / Proteomics #Therapeutics

New podcast on CROs and targeted protein degradation

This is the latest episode of the free narrated DDW podcast, “CROs and targeted protein degradation offer an exciting future”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “CROs: Drug discovery expertise on hand” and “Why the emergence… Read More

#News

UK
#Association of the British Pharmaceutical Industry #Immunology / Virology & Vaccines #Moderna #mRNA #Pharmaceuticals #Therapeutics

Moderna joins the Association of the British Pharmaceutical Industry 

Moderna has become the newest member of the UK’s pharmaceutical industry body, the Association of the British Pharmaceutical Industry (ABPI), building on the long-term commitment by the American-based company to expand its footprint and investment in the UK.  Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics… Read More

#News

Human neurone
#Biosciences #Genetic diseases #Ion channels #Neurology #Neuroscience #Rare disease #Therapeutics

Ion channel modulators for ultra-rare genetic disorder 

Metrion Biosciences, a specialist ion channel contract research and drug discovery company, and The KCNC1 Foundation, a not-for-profit organisation focused on the development of a treatment for an ultra-rare genetic disorder, have entered a collaboration to progress a hit identification research project for small molecule modulators of the potassium… Read More

#News